Nrx Pharmaceuticals, INC. (NRXP) — SEC Filings

Latest SEC filings for Nrx Pharmaceuticals, INC.. Recent 8-K filing on Mar 24, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Nrx Pharmaceuticals, INC. on SEC EDGAR

Overview

Nrx Pharmaceuticals, INC. (NRXP) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Mar 24, 2026: NRX Pharmaceuticals, Inc. filed an 8-K on March 24, 2026, reporting on Item 5.02 regarding the departure or election of officers and their compensation, and Item 5.07 concerning matters submitted to a vote of security holders. This filing indicates potential changes in leadership or executive compen

Sentiment Summary

Across 1 filings, the sentiment breakdown is: 1 mixed. The dominant filing sentiment for Nrx Pharmaceuticals, INC. is mixed.

Filing Type Overview

Nrx Pharmaceuticals, INC. (NRXP) has filed 1 8-K with the SEC between Mar 2026.

Recent Filings (1)

Top Tags

officer-changes (1) · shareholder-vote (1) · corporate-governance (1)

Frequently Asked Questions

What are the latest SEC filings for Nrx Pharmaceuticals, INC. (NRXP)?

Nrx Pharmaceuticals, INC. has 1 recent SEC filings from Mar 2026, including 1 8-K. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of NRXP filings?

Across 1 filings, the sentiment breakdown is: 1 mixed. The dominant sentiment is mixed.

Where can I find Nrx Pharmaceuticals, INC. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Nrx Pharmaceuticals, INC. (NRXP) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Nrx Pharmaceuticals, INC.?

Financial highlights for Nrx Pharmaceuticals, INC. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.

What is the investment thesis for NRXP?

Investment thesis data for NRXP will be available once enriched filings are processed.

Who are the key executives at Nrx Pharmaceuticals, INC.?

Executive information for Nrx Pharmaceuticals, INC. is extracted from SEC filings as they are enriched with AI analysis.

What are the main risk factors for Nrx Pharmaceuticals, INC. stock?

Risk factor analysis for Nrx Pharmaceuticals, INC. is available when filings are enriched with AI risk assessment.

What are recent predictions and forward guidance from Nrx Pharmaceuticals, INC.?

Forward guidance and predictions for Nrx Pharmaceuticals, INC. are extracted from SEC filings as they are enriched.

View on Read The Filing